Pharmacy Usual Items - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Pharmacy Usual Items market is projected to reach US$19.42bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.28%, resulting in a market volume of US$21.74bn by 2029.
  • In global comparison, most revenue will be generated in China (US$48,050.00m in 2024).
  • In relation to total population figures, per person revenues of US$57.90 are generated in 2024.

Key regions: Japan, France, China, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmacy Usual Items market in Central & Western Europe is experiencing steady growth due to various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Pharmacy Usual Items market in Central & Western Europe have shifted towards a greater emphasis on health and wellness. Customers are becoming more conscious about their overall well-being and are seeking products that promote a healthy lifestyle. This has led to an increased demand for vitamins, supplements, and natural remedies. Additionally, there is a growing interest in organic and natural products, as customers are becoming more aware of the potential harmful effects of synthetic ingredients. Trends in the market are also contributing to the growth of the Pharmacy Usual Items market in Central & Western Europe. One notable trend is the rise of e-commerce and online shopping. Customers are increasingly turning to online platforms to purchase their usual items, as it offers convenience and a wider range of products. This trend has been further accelerated by the COVID-19 pandemic, as customers have been encouraged to stay at home and avoid physical stores. Another trend in the market is the increasing focus on sustainability and eco-friendliness. Customers are seeking products that are environmentally friendly and have a minimal impact on the planet. This has led to a rise in the demand for eco-friendly packaging, organic and natural ingredients, and cruelty-free products. Local special circumstances also play a role in the development of the Pharmacy Usual Items market in Central & Western Europe. Each country in the region has its own unique regulations and market dynamics, which can impact the availability and pricing of usual items. For example, some countries may have stricter regulations on the sale of certain products, while others may have a more competitive market with lower prices. Underlying macroeconomic factors also contribute to the growth of the Pharmacy Usual Items market in Central & Western Europe. Factors such as population growth, increasing disposable income, and improving healthcare infrastructure all play a role in driving demand for usual items. Additionally, changing demographics, such as an aging population, can also impact the market, as older individuals may have different health needs and preferences. Overall, the Pharmacy Usual Items market in Central & Western Europe is experiencing steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As customers continue to prioritize their health and wellness, and as new trends and technologies emerge, the market is expected to continue its positive trajectory.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)